4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001688199-26-000006
Director sold 2,778 shares at $117.55 ($326,554)
- Director acquired 2,778 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Read Simon Director | 2026-08-19 | Option exercise 10b5-1 | +2,778 | $18.36 | $51,004 | 2,778 | D |
| Read Simon Director | 2026-08-19 | Sale 10b5-1 | −2,778 | $117.55 | $326,554 | 0 | D |
| Derivatives | |||||||
| Read Simon Director | 2026-08-19 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,778 | 19,445 | D | ||
| Open-market sales · 2,778 sh · avg $117.55 · $326,554 | |||||||
Loading xslF345X06/ownership.xml…